Ozer , L. And Aydıner, A. ADJUVANT CHEMOTHERAPY FOR HER2-NEGATIVE EARLY STAGE BREAST CANCER. 2019. In BREAST CANCER - A GUIDE TO CLINICAL PRACTICE , Springer, London/Berlin , Geneve, 357-383.

Ozer , L., & Aydıner, A., (2019). ADJUVANT CHEMOTHERAPY FOR HER2-NEGATIVE EARLY STAGE BREAST CANCER. BREAST CANCER - A GUIDE TO CLINICAL PRACTICE (pp.357-383), Geneve: Springer, London/Berlin .

Ozer , LEYLA, And Adnan Aydıner. "ADJUVANT CHEMOTHERAPY FOR HER2-NEGATIVE EARLY STAGE BREAST CANCER." In BREAST CANCER - A GUIDE TO CLINICAL PRACTICE , 357-383. Geneve: Springer, London/Berlin , 2019

Ozer , LEYLA And Aydıner, Adnan. "ADJUVANT CHEMOTHERAPY FOR HER2-NEGATIVE EARLY STAGE BREAST CANCER." BREAST CANCER - A GUIDE TO CLINICAL PRACTICE , Springer, London/Berlin , 2019, pp.357-383.

Ozer , L. And Aydıner, A. (2019) "ADJUVANT CHEMOTHERAPY FOR HER2-NEGATIVE EARLY STAGE BREAST CANCER", BREAST CANCER - A GUIDE TO CLINICAL PRACTICE . Geneve: Springer, London/Berlin .

@bookchapter{bookchapter, author ={LEYLA OZER And author ={Adnan Aydıner}, chaptertitle={ADJUVANT CHEMOTHERAPY FOR HER2-NEGATIVE EARLY STAGE BREAST CANCER}, booktitle={ BREAST CANCER - A GUIDE TO CLINICAL PRACTICE }, publisher={Springer, London/Berlin }, city={Geneve},year={2019} }